Abacus FCF Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.92M Buy
20,694
+324
+2% +$67.3K 0.9% 50
2026
Q1
$4.3M Sell
20,370
-14,580
-42% -$3.14M 0.97% 50
2025
Q4
$7.18M Buy
+34,950
New +$6.58M 0.94% 47
2023
Q1
Sell
-9,239
Closed -$710K 142
2022
Q4
$710K Sell
9,239
-207
-2% -$15.7K 0.46% 101
2022
Q3
$629K Buy
+9,446
New +$599K 0.43% 111
2021
Q4
Sell
-14,060
Closed -$719K 129
2021
Q3
$719K Buy
14,060
+10
+0.1% +$542 0.35% 120
2021
Q2
$804K Sell
14,050
-1,034
-7% -$60.4K 0.41% 120
2021
Q1
$933K Buy
+15,084
New +$833K 0.47% 88
2015
Q1
Sell
-20,921
Closed -$1.69M 102
2014
Q4
$1.69M Buy
+20,921
New +$1.65M 1.04% 74

Other funds holding CAH

Abacus FCF Advisors's CAH Position: Q2 2026 in Review

Abacus FCF Advisors increased its Cardinal Health (CAH) stake by 1.6% in Q2 2026, buying an estimated $67.3K and bringing the position to 20,694 shares worth $4.92M. The position accounts for 0.9% of the portfolio, ranked #50.

Abacus FCF Advisors first reported a position in CAH in Q4 2014 and has held it in 9 quarters since. The position peaked at $7.18M in Q4 2025. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Abacus FCF Advisors held 20,694 shares of Cardinal Health worth $4.92M as of Q2 2026.
  • Abacus FCF Advisors bought 324 Cardinal Health shares in Q2 2026, an estimated $67.3K.
  • Cardinal Health made up 0.9% of Abacus FCF Advisors's portfolio in Q2 2026, its #50 holding.
  • Abacus FCF Advisors first reported a position in Cardinal Health in Q4 2014 and has held it in 9 quarters since.
  • Abacus FCF Advisors's Cardinal Health position peaked at $7.18M in Q4 2025.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Abacus FCF Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.